Identificación molecular y sensibilidad a los antifúngicos de aislamientos de sangre del complejo Candida parapsilosis en Venezuela

Morenoa, Xiomara; Reviakina, Vera; Panizo, María M; Ferrara, Giusseppe; García, Nataly; Alarcón, Víctor; Garcés, María F; Dolande, Maribel.
Rev. iberoam. micol ; 34(3): 165-170, jul.-sept. 2017. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-165195

Documentos relacionados

  1. Toward Harmonization of Voriconazole CLSI and EUCAST Breakpoints for Candida albicans Using a Validated <i>In Vitro</i> Pharmacokinetic/Pharmacodynamic Model.
  2. Exploring therapeutic avenues: mesenchymal stem/stromal cells and exosomes in confronting enigmatic biofilm-producing fungi.
  3. [One-Year Candida Data of the Central Mycology Laboratory: Which Sample, Which Species, How Resistant?]
  4. Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients.
  5. Trends in Implementation of Loading Dose of Voriconazole from 2010 to 2019 and Influencing Factors of Loading Dose Based on a Japanese Administrative Claim Database: A Retrospective Cohort Study.
  6. Rapid Antifungal Susceptibility Testing Based on Single-Cell Metabolism Analysis Using Stimulated Raman Scattering Imaging.
  7. Investigation of the Physiological, Biochemical and Antifungal Susceptibility Properties of Candida auris.
  8. <i>Candida auris</i> Genetics and Emergence.
  9. A systematic review on distribution and antifungal resistance pattern of Candida species in the Indian population.
  10. Genotyping and Drug Resistance Profile of Clinical Isolates of Candida albicans from Vulvovaginal Candidiasis in the Eastern China.